Generikusak

Generikusak refers to generic medications. These are pharmaceutical drugs that are equivalent in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use to a brand-name medication. Generic drugs are typically made available after the patent protection for the original brand-name drug expires. The active ingredient in a generic drug is the same as in the brand-name drug, meaning it works in the same way and provides the same therapeutic effect.

The development and approval process for generic drugs is overseen by regulatory agencies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe. These agencies require generic manufacturers to demonstrate that their product is bioequivalent to the brand-name drug. Bioequivalence means that the generic drug is absorbed into the bloodstream and reaches its target site in the body at the same rate and extent as the brand-name drug.

The primary advantage of generic medications is their lower cost. Because generic manufacturers do not have the extensive research and development costs associated with creating a new drug, they can offer their products at a significantly reduced price. This makes essential medications more accessible and affordable for patients and healthcare systems. While the inactive ingredients may differ, they must be proven safe and not affect the drug's performance. Patients can often choose between brand-name and generic versions of a prescription, and in many cases, the generic option is recommended due to its cost-effectiveness.